The American College of Cardiology has issued new guidelines recommending weight management medications as first-line treatments for eligible patients. This contrasts with prior guidelines that ...
Semaglutide or tirzepatide should be first-line drugs for obesity and most of its related complications, new guidance from the European Association for the Study of Obesity recommended. The authors of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results